SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-034609
Filing Date
2022-02-10
Accepted
2022-02-10 17:01:03
Documents
2
Group Members
APEIRON PRESIGHT CAPITAL FUND II, L.P.CHRISTIAN ANGERMAYERFABIAN HANSENPRESIGHT CAPITAL MANAGEMENT I, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G d274387dsc13g.htm SC 13G 102384
2 EX-99 d274387dex99.htm EX-99 6078
  Complete submission text file 0001193125-22-034609.txt   110233
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93405 | Film No.: 22615056
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13G